All‐oral direct‐acting antiviral therapy against hepatitis C virus (HCV) in human immunodeficiency virus/HCV–coinfected subjects in real‐world practiceJuan Berenguer, Juan González‐García, G. Gaspar et al.|Hepatology|2018Cited by 79
Reinfection by hepatitis C virus following effective all-oral direct-acting antiviral drug therapy in HIV/hepatitis C virus coinfected individualsJuan Berenguer, Juan González‐García, Lourdes Domínguez et al.|AIDS|2018Cited by 58
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemiaCristina Rueda, Rafael Zaragoza, Ignacio Gadea et al.|Clinical Microbiology and Infection|2016Cited by 57
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohortLuis Eduardo López-Cortés, David Navarro, Yolanda Romero et al.|Clinical Microbiology and Infection|2016Cited by 39
HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1Juan Berenguer, Juan González‐García, Antonio Olveira et al.|Open Forum Infectious Diseases|2019Cited by 4